|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/395 | |||
| G01N 33/48 |
| (11) | Number of the document | 3033103 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14836392.2 |
| Date of filing the European patent application | 2014-08-07 | |
| (97) | Date of publication of the European application | 2016-06-22 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/050122 |
| Date | 2014-08-07 |
| (87) | Number | WO 2015/023508 |
| Date | 2015-02-19 |
| (30) | Number | Date | Country code |
| 201361864950 P | 2013-08-12 | US |
| (72) |
WARD, Christine, US
ROSKOS, Lorin, US
WANG, Bing, US
RAIBLE, Donald, US
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | METHODS FOR IMPROVING ASTHMA SYMPTOMS USING BENRALIZUMAB |
| METHODS FOR IMPROVING ASTHMA SYMPTOMS USING BENRALIZUMAB |